Thalidomide shows efficacy as adjuvant therapy for hepatocellular carcinoma patients, study suggests
Saturday, April 2, 2011 - 16:30
in Health & Medicine
Thalidomide has shown potential to be used as the first adjuvant therapy for hepatocellular carcinoma, according to new data.